BORAYBora Pharmaceuticals Co., Ltd.

About Bora Pharmaceuticals Co., Ltd. (BORAY)

Bora Pharmaceuticals Co., Ltd. (BORAY) is a company headquartered in Taipei, Taiwan whose shares trade over-the-counter on the OTCQX tier.

Founded in 2007, Bora Pharmaceuticals continues to gain industry trust, significantly expanding market penetration through premium CDMO services. The Company’s distinctive dual-engine strategy integrates scalable, high-quality CDMO growth with innovative drug development focused on specialty pharma and rare diseases. Strategic investments in manufacturing capabilities, operational excellence, and specialized talents are the pillars that sustain Bora’s valued partnerships in the industry. The Company advances access to transformative treatments by enabling genuine, decisive progress.

Products and services

The Company’s contract development and manufacturing business specializes in complex oral solid dosage (tablet and capsules), biologics, liquids (solutions, suspensions, ophthalmic & nasal sprays), powders, semi-solids (creams, ointments & gels), and sterile injectables for pharmaceutical products for clinical through commercial manufacturing and packaging. Its pharmaceutical sales business, consolidated under Upsher-Smith, is anchored by infantile and rare disease therapies, complemented by a portfolio of high-value generics in the U.S. market.

BORAY key facts

Ticker symbol

BORAY

Market tier

OTCQX

Headquarters

Taipei, Taiwan

Country of incorporation

TW

Year of incorporation

2007

Employees

2,100

Shares outstanding

127,363,633

Reporting standard

International Reporting: Taiwan Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Bora Pharmaceuticals Co., Ltd. leadership

• Pao-Shi Sheng — CEO
• Alice Wang — CFO
• Andrew Chen — Consultant
• Ted Feng — Consultant
• Nadiya Chen — IR

Explore more: OTCQX stocks · OTC stocks starting with B